Showing results (71-80 of 141) with videos related to
Sort By:
Pageof 15
Ejhaem|February 26, 2024
Patient and clinician beliefs about potential barriers to treatment of neuropathic pain for adolescents with sickle cell diseaseMatthew Rees, Holly Spraker-Perlman, Raechyl Moore, et al.Blood|April 26, 2003
Placenta growth factor activates monocytes and correlates with sickle cell disease severityNatalya Perelman, Suresh K Selvaraj, Sandeep Batra, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|August 27, 2009
Genotoxic potential of lineage-specific lentivirus vectors carrying the beta-globin locus control regionParitha I Arumugam, Tomoyasu Higashimoto, Fabrizia Urbinati, et al.Blood|January 26, 2013
Erythrocyte NADPH oxidase activity modulated by Rac GTPases, PKC, and plasma cytokines contributes to oxidative stress in sickle cell diseaseAlex George, Suvarnamala Pushkaran, Diamantis G Konstantinidis, et al.Blood|May 17, 2017
Association between diffuse myocardial fibrosis and diastolic dysfunction in sickle cell anemiaOmar Niss, Robert Fleck, Fowe Makue, et al.Plastic and Reconstructive Surgery. Global Open|November 10, 2025
Benefits of Antifibrinolytics in Minimally Invasive Surgical Repair of Single-suture CraniosynostosisGabrielle C Rodriguez, Anitesh Bajaj, Parul Rai, et al.Pediatric Blood & Cancer|April 22, 2024
Association of elevated tricuspid regurgitation velocity with cerebrovascular and kidney disease in children with sickle cell diseaseChibuzo Ilonze, Parul Rai, Najibah Galadanci, et al.Blood. Red Cells & Iron|November 28, 2025
Longitudinal changes and predictors of cardiac extracellular volume fraction in sickle cell anemiaOmar Niss, Cara E Morin, Sassan Hashemi, et al.Molecular Therapy. Methods & Clinical Development|June 9, 2015
Pigtailed macaques as a model to study long-term safety of lentivirus vector-mediated gene therapy for hemoglobinopathiesHans-Peter Kiem, Paritha I Arumugam, Christopher R Burtner, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|September 14, 2013
Quantification of the 5-lipoxygenase inhibitor zileuton in human plasma using high performance liquid chromatography-tandem mass spectrometryPhillip Pian, Edward Labovitz, Keith Hoffman, et al.Pageof 15